News Merck & Co pulls Keytruda lung cancer filing in Europe Blow for Merck as Keytruda sales top $1 billion per quarter.
News Novartis adds to cancer reach with $3.9 billion acquisition Novartis backs ambition to be oncology world-leader
News Celgene under pressure as growth slows Celgene has revealed disappointing Q3 results and scaled back forecasts for 2020, news which has caused its share price to plunge 18% yesterday.
News Microsoft, Parexel team up to accelerate drug development Partnership aims to create tools to improve patient engagement and recruitment.
News Novartis Q3: Cosentyx growing fast, no decision yet on Alcon Novartis saw its sales rise 2% in the third quarter, thanks to steady overall growth in its innovative medicines division, and a strong 7% increase from its Alcon eye division.
Patients Patients not just at the table, but creating their own: In c... Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
